Vanessa A Ravel1, Elani Streja1, Rajnish Mehrotra2, John J Sim3, Kevin Harley1, Juan Carlos Ayus4, Alpesh N Amin5, Steven M Brunelli6, Csaba P Kovesdy7,8, Kamyar Kalantar-Zadeh1, Connie M Rhee1. 1. Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA. 2. Kidney Research Institute and Harborview Medical Center, University of Washington, Seattle, WA, USA. 3. Division of Nephrology, Kaiser Permanente Southern California, Los Angeles, CA, USA. 4. Renal Consultants of Houston, Houston, TX, USA. 5. Department of Medicine, University of California Irvine Medical Center, Orange, CA, USA. 6. DaVita Clinical Research, Minneapolis, MN, USA. 7. University of Tennessee Health Science Center, Memphis, TN, USA. 8. Memphis Veterans Affairs Medical Center, Memphis, TN, USA.
Abstract
BACKGROUND: Sodium disarrays are common in peritoneal dialysis (PD) patients, and may be associated with adverse outcomes in this population. However, few studies of limited sample size have examined the association of serum sodium with mortality in PD patients, with inconsistent results. We hypothesized that both hypo- and hypernatremia are associated with higher death risk in a nationally representative cohort of US PD patients. METHODS: We sought to examine the association of serum sodium over time and mortality among 4687 adult incident PD patients from a large US dialysis organization who underwent one or more serum sodium measurements within the first 3 months of dialysis over January 2007 to December 2011. We examined the association of time-dependent and baseline sodium with all-cause mortality as a proxy of short- and long-term sodium-mortality associations, respectively. Hazard ratios were estimated using Cox models with three adjustment levels: minimally adjusted, case-mix adjusted, and case-mix + laboratory adjusted. RESULTS: In time-dependent analyses, sodium levels <140 mEq/L were associated with incrementally higher death risk in case-mix models (ref: 140 to <142 mEq/L); following laboratory covariate adjustment, associations between lower sodium and higher mortality remained significant for levels <136 mEq/L. In analyses using baseline values, sodium levels <140 mEq/L were associated with higher mortality risk across all models (ref: 140 to <142 mEq/L). CONCLUSIONS: In PD patients, lower time-dependent and baseline sodium levels were independently associated with higher death risk. Further studies are needed to determine whether correction of dysnatremia improves longevity in this population.
BACKGROUND: Sodium disarrays are common in peritoneal dialysis (PD) patients, and may be associated with adverse outcomes in this population. However, few studies of limited sample size have examined the association of serum sodium with mortality in PD patients, with inconsistent results. We hypothesized that both hypo- and hypernatremia are associated with higher death risk in a nationally representative cohort of US PD patients. METHODS: We sought to examine the association of serum sodium over time and mortality among 4687 adult incident PD patients from a large US dialysis organization who underwent one or more serum sodium measurements within the first 3 months of dialysis over January 2007 to December 2011. We examined the association of time-dependent and baseline sodium with all-cause mortality as a proxy of short- and long-term sodium-mortality associations, respectively. Hazard ratios were estimated using Cox models with three adjustment levels: minimally adjusted, case-mix adjusted, and case-mix + laboratory adjusted. RESULTS: In time-dependent analyses, sodium levels <140 mEq/L were associated with incrementally higher death risk in case-mix models (ref: 140 to <142 mEq/L); following laboratory covariate adjustment, associations between lower sodium and higher mortality remained significant for levels <136 mEq/L. In analyses using baseline values, sodium levels <140 mEq/L were associated with higher mortality risk across all models (ref: 140 to <142 mEq/L). CONCLUSIONS: In PD patients, lower time-dependent and baseline sodium levels were independently associated with higher death risk. Further studies are needed to determine whether correction of dysnatremia improves longevity in this population.
Authors: K Ateş; G Nergizoğlu; K Keven; A Sen; S Kutlay; S Ertürk; N Duman; O Karatan; A E Ertuğ Journal: Kidney Int Date: 2001-08 Impact factor: 10.612
Authors: Juan Carlos Ayus; Daniel Caputo; Fernando Bazerque; Ricardo Heguilen; Claudio D Gonzalez; Michael L Moritz Journal: Am J Kidney Dis Date: 2014-11-25 Impact factor: 8.860
Authors: Sinead Kinsella; Sarah Moran; Miriam O Sullivan; Michael G M Molloy; Joseph A Eustace Journal: Clin J Am Soc Nephrol Date: 2010-01-07 Impact factor: 8.237
Authors: Anastasia Markaki; Periklis Kyriazis; Eleftheria-Kleio Dermitzaki; Sevasti Maragou; Emmanuel Psylinakis; Aspasia Spyridaki; Helen Drosataki; Dimitra Lygerou; Maria G Grammatikopoulou; Ioannis Petrakis; Kostas Stylianou Journal: Front Med (Lausanne) Date: 2021-01-12